Open Heart

OCTOBER 1, 2024

Background The prognosis of myocardial ischaemia with no obstructive coronary artery disease (INOCA) and its underlying vasomotor disorders, vasospastic angina (VSA) and microvascular angina (MVA), is not well defined.

Coronary Artery Disease 52

Coronary Artery Disease Outcomes Angina Myocardial Infarction 52

DAIC

FEBRUARY 23, 2024

The Cleerly ISCHEMIA software provides noninvasive estimates of FFR values that help healthcare professionals make critical decisions in the management of patients with suspected coronary artery disease," said James P. "The Presented at the Society of Cardiovascular Computed Tomography Annual Scientific Meeting Boston MA 2023.

Ischemia 105

Ischemia Coronary Artery Disease Physiology Cardiovascular Imaging 105

DAIC

JANUARY 23, 2024

a leader in non-invasive artificial intelligence (AI) precision coronary solutions, announced FFRCT was transitioned to a Category I Current Procedural Terminology (CPT) code beginning January 1, 2024. milla1cf Tue, 01/23/2024 - 13:44 January 23, 2024 — HeartFlow, Inc. ,

Reimbursement 105

Reimbursement Coronary Artery Disease CMS Technology 105

Dr. Paddy Barrett

APRIL 26, 2024

Coronary artery disease is caused by the retention of a cholesterol particle in the artery wall. Insulin resistance and diabetes may not ‘ cause ’ coronary artery disease, but they are huge accelerants. If delaying the onset of major chronic disease is your goal. Timing Matters.

Heart Disease 105

Heart Disease Coronary Artery Disease Diabetes Genetic predisposition 105

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years. 10390, May 2023, pp.

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

MARCH 28, 2025

v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians.

Technology 52

Technology Coronary Artery Disease Atrial Fibrillation Medicare 52

DAIC

JANUARY 3, 2024

6 Also in 2023, HeartFlow released its RoadMap Analysis which helps identify and quantify narrowings in the coronary arteries and has demonstrated a 25% faster CCTA read time. REVEALPLAQUE Study, SCCT 2023. HeartFlow is committed to serving customers quickly and reliably with a median turnaround time less than 1.5

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

DAIC

DECEMBER 13, 2023

MILLER, PHD, LED THE DEVELOPMENT OF A NEW "ATHEROSCLEROSIS ATLAS" THAT DETAILS, AT THE LEVEL OF INDIVIDUAL CELLS, CRITICAL PROCESSES RESPONSIBLE FOR FORMING THE HARMFUL PLAQUE BUILDUP THAT CAUSES HEART ATTACKS, STROKES AND CORONARY ARTERY DISEASE.

Heart Attack 105

Heart Attack Heart attacks Atherosclerosis Stroke 105

Journal of the American Heart Association

DECEMBER 1, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundCoronary computed tomography angiography is increasingly used as the first‐line test for suspected coronary artery disease. PTP was calculated according to the 2013 and 2019 ESC guidelines.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction Angina Hospital 40

Dr. Paddy Barrett

SEPTEMBER 28, 2024

Almost every patient we saw had advanced obstructive coronary artery disease. For many of these patients (but not all), their coronary artery disease was avoidable. But I was in the wrong place. At least until much later in life. It wasn’t long before I completely burned out.

Coronary Artery Disease 96

Coronary Artery Disease Heart Disease Interventional Cardiology Download 96

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. The DynamX bioadaptor has a novel design and mechanism of action designed to return the diseased vessel to a more normal condition, through three distinct phases.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

DECEMBER 19, 2023

milla1cf Tue, 12/19/2023 - 17:05 December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration ( FDA ) clearance of the Somatom Pro.Pulse, a dual-source computed tomography scanner designed to be more affordable for a wide range of healthcare facilities, including outpatient diagnostic centers.

Chest Pain 104

Chest Pain Coronary Artery Disease Technology Outpatient 104

DAIC

MARCH 20, 2024

Our efforts to expand therapeutic possibilities, underlined by the introduction of the Freesolve RMS for coronary artery disease treatment, will continue in the BTK indication with this groundbreaking innovation.” Eurointervention; 2023;18-online publish-ahead-of-print January 2023. 4 Seguchi M.,

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

Circulation

NOVEMBER 11, 2024

We evaluated patterns of evidence-based prescription of SGLT2i and GLP1RA over time and by race in US Veterans with T2D and coronary artery disease (CAD).Results:Of We evaluated patterns of evidence-based prescription of SGLT2i and GLP1RA over time and by race in US Veterans with T2D and coronary artery disease (CAD).Results:Of

Coronary Artery Disease 40

Coronary Artery Disease Diabetes Circulation Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

Odds ratios (OR) were pooled using a random-effect model, and a p-value of <0.05 was considered statistically significant.Results:A total of 15 randomized controlled trials were included (6863 in Colchicine and 6756 in the control group) in the analysis.

Coronary Artery Disease 40

Coronary Artery Disease Stroke Strokes Myocardial Infarction 40

DAIC

JUNE 27, 2024

Attendees can join with their peers and participate in sessions on structural heart disease, congenital heart disease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, vascular heart disease, debates and games and early career topics. for all attendees.

Congenital Heart Disease 105

Congenital Heart Disease Coronary Artery Disease Congenital Heart Disease 105

The American Journal of Cardiology

DECEMBER 13, 2023

Publication date: Available online 19 November 2023 Source: The American Journal of Cardiology Author(s): Yuko Kiyohara, Tadao Aikawa, Keigo Kayanuma, Hisato Takagi, Polydoros N. Kampaktsis, Jose Wiley, Toshiki Kuno

Coronary Artery Disease 40

Coronary Artery Disease Outcomes 40

Circulation: Genomic and Precision Medicine

SEPTEMBER 27, 2023

Circulation: Genomic and Precision Medicine, Volume 16, Issue 5 , Page 442-451, October 1, 2023. Background:Patients with de novo chest pain, referred for evaluation of possible coronary artery disease (CAD), frequently have an absence of CAD resulting in millions of tests not having any clinical impact.

Chest Pain 40

Chest Pain Coronary Artery Disease Risk Factors Circulation 40

DAIC

MARCH 28, 2024

"This pivotal study was performed in two different international populations which shows that CCTA analyzed with the Cleerly AI-QCT ISCHEMIA device provides an accurate assessment of coronary ischemia,” said James P. 2023 Mar, 81 (8_Supplement) 1362. Earls, MD , Chief Medical Officer of Cleerly. J Am Coll Cardiol.

Ischemia 110

Ischemia Chest Pain Atherosclerosis Coronary Artery Disease 110

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

DAIC

JANUARY 15, 2024

This builds on the history of Echo diagnostic algorithms developed by Ultromics including the first ever AI diagnostic, EchoGo® Pro for the detection of coronary artery disease, which was FDA cleared in 2021 and is undergoing a prospective clinical trial in the UK.

Ultrasound 119

Ultrasound Coronary Artery Disease Innovation Heart Failure 119

Circulation: Genomic and Precision Medicine

JULY 6, 2023

Circulation: Genomic and Precision Medicine, Volume 16, Issue 5 , Page 480-482, October 1, 2023.

Coronary Artery Disease 40

Coronary Artery Disease Cholesterol Atherosclerosis Circulation 40

Dr. Paddy Barrett

JANUARY 30, 2024

The key issue when it comes to the near-term risk of a heart attack is whether you already have coronary artery disease and how much of it. It’s not a good test for assessing for plaque in the arteries. 2023, 2 Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med.

Heart Disease 95

Heart Disease Heart Attack Heart attacks Plaque 95

Dr. Paddy Barrett

OCTOBER 11, 2024

Between 2020 and 2023, the rates of obesity dropped by about 2% 2. Inflammation is a key driver of heart disease, specifically coronary artery disease. Sci Rep 13 , 20998 (2023). 2023 Dec 14;389(24):2221-2232. For over 50 years, the rates of obesity have continued to rise worldwide 1. Inflammation.

Obesity 84

Obesity Cancer Dementia Coronary Artery Disease 84

Journal of the American Heart Association

FEBRUARY 26, 2025

This study aims to investigate the relationship between sdLDLC level and PP in patients with stable coronary artery disease.MethodsWe conducted a retrospective analysis of 146 lesions in 86 patients by repeat intravascular ultrasound examinations from January 2020 to May 2023.

Ultrasound 56

Ultrasound Plaque Cholesterol Coronary Artery Disease 56

Dr. Paddy Barrett

FEBRUARY 27, 2024

mmol/l (130 mg/dl) or below, between 20-50% will already have coronary artery disease. As HBA1c increases, even in the normal range, the probability of coronary artery disease increases. 2023 Nov, 82 (22) 2152–2162. For HBA1c, the trend is similar. JAMA Cardiol. 2020;5(9):1011–1018.

Risk Factors 111

Risk Factors Heart Disease Heart Attack Heart attacks 111

American College of Cardiology

FEBRUARY 1, 2025

Self-reported adherence to cardiovascular medications in patients who have coronary artery disease is for the combination of aspirin, beta-blocker and a lipid-lowering agent in surveys.7 American Geriatrics Society 2023 Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

Frontiers in Cardiovascular Medicine

FEBRUARY 12, 2024

Background There is mounting data supporting the use of drug-coated balloons (DCB) not only for treatment of in-stent restenosis (ISR), but also in native coronary artery disease. The mean age was 68 ± 10 years, 48 (38%) patients had an acute coronary syndrome. Angiograms and outcomes were independently adjudicated.

Coronary Artery Disease 59

Coronary Artery Disease Myocardial Infarction Stents Stent 59

Dr. Paddy Barrett

OCTOBER 4, 2024

But the goal in this instance is to die after a long and healthy life ‘ with ’ coronary artery disease rather than ‘ from ’ coronary artery disease. However, the chances of dying from heart disease are directly proportional to the amount of plaque in your coronary arteries.

Heart Disease 104

Heart Disease Plaque Cholesterol Risk Factors 104

Heart 2023 Conference

JANUARY 17, 2024

The institute specializes in the treatment of coronary artery diseases, arrhythmia, advanced heart failure and heart transplantation, structural heart disease, cardiogenetics, and congenital heart disease. Additionally, it offers comprehensive cardiac screening and preventive care.

Congenital Heart Disease 49

Congenital Heart Disease Coronary Artery Disease Heart Transplant Transplant 49

DAIC

JANUARY 8, 2024

Our anticipated acquisition of MIM Software will mark a key moment in the evolution of our technology.

Innovation 105

Innovation Technology Patient Care Coronary Artery Disease 105

Open Heart

SEPTEMBER 19, 2024

Methods Patients with symptomatic PAF who underwent RFCA between October 2021 and May 2023 were retrospectively analysed. Compared with the PVI group, patients in the PVI+SVCI group had a higher prevalence of coronary artery disease (p=0.04), stroke (p=0.02) and a smaller left atrial diameter (p<0.01).

Atrial Fibrillation 52

Atrial Fibrillation Ablation Atrial Flutter Coronary Artery Disease 52

Dr. Paddy Barrett

JANUARY 23, 2024

By age 66, more than half of all females will have evidence of advanced plaque in their coronary arteries, as seen on a CT calcium score. Subscribe now But are there groups who buck this trend and rarely develop coronary artery disease and, by extension, do not die from it early in life? 2023 Jan;19(1):44-55.

Heart Disease 105

Heart Disease Blood Pressure Dementia Atherosclerosis 105

DAIC

OCTOBER 16, 2024

The LCDs have a future effective date of Nov. The LCDs have a future effective date of Nov.

CMS 52

CMS Medicare Plaque Chest Pain 52

Journal of Cardiovascular Pharmacology

JANUARY 8, 2024

Traditional Chinese herbal medicine (CHM) has been extensively used in cardiovascular disease in modern clinical practice, alone or in combination with conventional treatment. From inception until August 2023, we systematically searched five public literature databases to conduct the umbrella review.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease Angina Heart Failure 40

BoardVitals - Cardiovascular

MAY 15, 2022

The Cardiology MOC exam will be offered on April 3, 2023, and October 11, 2023. The Cardiology MOC exam covers the following subjects : Arrhythmias 15% Coronary Artery Disease 21.5% What are some things you need to know before you sit for the exam? How much does the exam cost? What does the exam cover?

Certification 52

Certification Congenital Heart Disease Coronary Artery Disease Cardiovascular Disease 52

Dr. Paddy Barrett

OCTOBER 31, 2023

An elevated Lp(a) is a common genetic factor that is independently and causally related to premature coronary artery disease. The occurrence of disease in this instance is probabilistic, not deterministic. An elevated Lp(a) does increase the risk of early cardiovascular disease, but that risk is not set in stone.

Coronary Artery Disease 52

Coronary Artery Disease Heart Disease Atherosclerosis Cardiovascular Disease 52